A mutation in the human neurofilament M gene in Parkinson's disease that suggests a role for the cytoskeleton in neuronal degeneration

Neurosci Lett. 2002 Mar 29;322(1):57-61. doi: 10.1016/s0304-3940(01)02513-7.

Abstract

Parkinson's disease (PD) is a common neurodegenerative movement disorder characterized by the destruction of dopaminergic neurons of the substantia nigra. We have identified a new mutation (Gly336Ser) in the medium neurofilament subunit in a patient of French-Canadian origin with early onset severe PD. This finding suggests, for the first time, that aberrations in neuronal molecules involved in the cytoskeleton could lead to the development of the pathology seen in PD.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age of Onset
  • Brain / metabolism*
  • Brain / pathology
  • Brain / physiopathology
  • Cytoskeleton / genetics*
  • Cytoskeleton / metabolism
  • Cytoskeleton / pathology
  • DNA Mutational Analysis
  • Female
  • Genetic Testing
  • Glycine / genetics
  • Humans
  • Male
  • Molecular Sequence Data
  • Mutation / genetics*
  • Neurofilament Proteins / genetics*
  • Neurofilament Proteins / metabolism
  • Neurons / metabolism*
  • Neurons / pathology
  • Parkinsonian Disorders / genetics*
  • Parkinsonian Disorders / metabolism
  • Parkinsonian Disorders / physiopathology
  • Sequence Homology, Amino Acid
  • Sequence Homology, Nucleic Acid
  • Serine / genetics

Substances

  • Neurofilament Proteins
  • neurofilament protein M
  • Serine
  • Glycine